Class iii slrp for the treatment of cancer

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2626774

There is provided the use of an agent that promotes class III SLRP activity in the manufacture of a medicament for the prevention and/or treatment of cancer. Such medicaments may be used in the treatment of tumours, including avascular tumours. Suitable agents to be used may preferably include the class III SLRPs opticin; epiphycan; or mimecan. The invention also provides a method for the prevention and/or treatment of cancer.

L'invention concerne l'utilisation d'un agent qui promeut l'activité SLRP de classe III dans la fabrication d'un médicament destiné à prévenir et/ou à traiter le cancer. Ces médicaments peuvent être utilisés dans le traitement de tumeurs, notamment des tumeurs avasculaires. Des agents adaptés à cette utilisation contiennent de préférence de l'opticine SLRP de classe III, de l'épiphycane ou du mimécane. L'invention concerne également un procédé destiné à prévenir et/ou à traiter le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Class iii slrp for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Class iii slrp for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Class iii slrp for the treatment of cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1958791

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.